{"brief_title": "Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression", "brief_summary": "The purpose of this study is to examine the effectiveness of ethyl-eicosapentanoic acid (ethyl-EPA), an omega-3 fatty acid, in treating depression.", "detailed_description": "Evidence suggests that omega-3 fatty acids may help reduce symptoms of depression. This study will determine whether ethyl-EPA, an omega-3 fatty acid, can be used safely and effectively to treat major depression. Participants will be randomly assigned to receive either ethyl EPA-containing pills or placebo daily for 8 weeks. Each week, participants will be asked to complete questionnaires which will be used to assess the severity of their depression.", "condition": ["Depressive Disorder", "Depression"], "intervention_type": ["Drug"], "intervention_name": ["Ethyl-eicosapentanoic acid (ethyl-EPA)"], "criteria": "Inclusion Criteria: - Major depressive disorder Exclusion Criteria: - Serious comorbid psychiatric disorder - Unstable medical illness - Prior use of any omega-3 fatty acid product", "gender": "All", "minimum_age": "18 Years", "maximum_age": "80 Years", "healthy_volunteers": "No", "keyword": "Eicosapentanoic Acid", "mesh_term": ["Depression", "Depressive Disorder"], "id": "NCT00096798"}